Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.
about
The clinical utility of lurasidone in schizophrenia: patient considerationsLong-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management.Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia.
P2860
Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Daytime sleepiness associated ...... n patients with schizophrenia.
@en
Daytime sleepiness associated ...... n patients with schizophrenia.
@nl
type
label
Daytime sleepiness associated ...... n patients with schizophrenia.
@en
Daytime sleepiness associated ...... n patients with schizophrenia.
@nl
prefLabel
Daytime sleepiness associated ...... n patients with schizophrenia.
@en
Daytime sleepiness associated ...... n patients with schizophrenia.
@nl
P2093
P2860
P1433
P1476
Daytime sleepiness associated ...... n patients with schizophrenia.
@en
P2093
Andrei A Pikalov
Antony D Loebel
Cynthia O Siu
Josephine B Cucchiaro
P2860
P304
P356
10.1017/S1092852913000904
P577
2013-12-13T00:00:00Z